About
Doug Roeder has invested more than $250M into early-stage medical technology companies over his career and has maintained over two decades of continuity at Delphi Ventures, joining as an associate in 1998 and becoming a partner by 2000. He combines his venture investing role with public company board experience, serving as an independent director of Senseonics Holdings, a publicly traded medical device company. Doug Roeder has invested more than $250M into early-stage medical technology companies over his career and has maintained over two decades of continuity at Delphi Ventures, joining as an associate in 1998 and becoming a partner by 2000. He combines his venture investing role with public company board experience, serving as an independent director of Senseonics Holdings, a publicly traded medical device company.
